28 related articles for article (PubMed ID: 2155644)
1. Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis.
Cheng G; Zhang Q; Pan J; Lee Y; Ouari O; Hardy M; Zielonka M; Myers CR; Zielonka J; Weh K; Chang AC; Chen G; Kresty L; Kalyanaraman B; You M
Nat Commun; 2019 May; 10(1):2205. PubMed ID: 31101821
[TBL] [Abstract][Full Text] [Related]
2. Relative cytotoxicities of adriamycin and epirubicin in combination with lonidamine against human bladder cancer cell lines.
Popert RJ; Masters JR; Coptcoat M; Zupi G
Urol Res; 1995; 22(6):367-72. PubMed ID: 7740656
[TBL] [Abstract][Full Text] [Related]
3. New perspectives in lung cancer.5. New drugs in lung cancer.
Talbot DC; Smith IE
Thorax; 1992 Mar; 47(3):188-94. PubMed ID: 1325676
[No Abstract] [Full Text] [Related]
4. Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors.
Di Cosimo S; Ferretti G; Papaldo P; Carlini P; Fabi A; Cognetti F
Drugs Today (Barc); 2003 Mar; 39(3):157-74. PubMed ID: 12730701
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy plus lonidamine in non-small cell lung cancer.
Cionini L
Semin Oncol; 1991 Apr; 18(2 Suppl 4):49-52. PubMed ID: 1851578
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of lonidamine in non-small cell lung cancer: final report.
Kokron O; Maca S; De Gregorio M; Ciottoli GB
Br J Cancer; 1990 Feb; 61(2):316-8. PubMed ID: 2155644
[TBL] [Abstract][Full Text] [Related]
7. Chronic administration of lonidamine in untreated non-small cell lung cancer of stage III M0-1.
Scagliotti GV; Gozzelino F; Albera C; Pescetti G
Chemotherapy; 1989; 35(1):64-8. PubMed ID: 2541978
[TBL] [Abstract][Full Text] [Related]
8. A randomised trial of MACC chemotherapy with or without lonidamine in advanced non-small cell lung cancer. Cuneo Lung Cancer Study Group (CuLCaSG).
Buccheri G; Ferrigno D
Eur J Cancer; 1994; 30A(10):1424-31. PubMed ID: 7833096
[TBL] [Abstract][Full Text] [Related]
9. Phase II double-blind randomized study of lonidamine and radiotherapy in epidermoid carcinoma of the lung.
Privitera G; Ciottoli GB; Patanè C; Palmucci T; Tafuri G; Marletta F; De Luca B; Magnani F; De Gregorio M; Greco S
Radiother Oncol; 1987 Dec; 10(4):285-90. PubMed ID: 3444905
[TBL] [Abstract][Full Text] [Related]
10. Lonidamine in non-small-cell lung cancer: a phase II study.
Contu A; Olmeo NA; Pani P; Deriu A; Ortu S; Paga C
Tumori; 1991 Feb; 77(1):52-5. PubMed ID: 1850177
[TBL] [Abstract][Full Text] [Related]
11. Reporting results of cancer treatment.
Miller AB; Hoogstraten B; Staquet M; Winkler A
Cancer; 1981 Jan; 47(1):207-14. PubMed ID: 7459811
[TBL] [Abstract][Full Text] [Related]
12. The embryotoxicity of a new class of antispermatogenic agents: the 3-indazole-carboxylic acids.
Scorza Barcellona P; Campana A; Silvestrini B; De Martino C
Arch Toxicol Suppl; 1982; 5():197-201. PubMed ID: 6954899
[TBL] [Abstract][Full Text] [Related]
13. Effects of lonidamine alone or combined with hyperthermia in some experimental cell and tumour systems.
Silvestrini B; Hahn GM; Cioli V; De Martino C
Br J Cancer; 1983 Feb; 47(2):221-31. PubMed ID: 6824568
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of lonidamine in inoperable non-small-cell lung cancer.
Kokron O; Maca S; Scheiner W; De Gregorio M; Ciottoli GB
Oncology; 1984; 41 Suppl 1():86-9. PubMed ID: 6717902
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
